Welcome to Valion Bio, Inc.'s conference call to discuss first quarter 2026 financial results. This call has been prerecorded. The call is being webcast, and the replay will be available on the ...
The CDC stressed that the public remains at low risk during a briefing on hantavirus. Here's what to know as they monitor ...
Company Highlights Second Positive DSMB Review of Interim Data from Ovaprene® Phase 3 Clinical Trial, DARE to PLAY™ ...
Cabaletta Bio (CABA) remains a Buy: rese-cel trial catalysts, autoimmune upside, scalable manufacturing, and key risks like ...
The Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of the university's health and medical technology discoveries into cures, today announced it will sponsor ...
BioHarvest Sciences Inc. (BHST) delivered earnings and revenue surprises of +15.39% and +0.02%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the ...
INmune Bio Inc. (NASDAQ: INMB), a late-stage biotechnology company focused on inflammation and immunology, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results